4FDA.Cumulative List Designated Approved Orphan Products[OL].http://wwwrarediseases.org/.2009-05-05.
5王海英.美国药品申报与法规管理[M].北京:中国医药科技出版社.2005.69-70.
6FDA-Tax Credit for Testing Expenses for Drugs for Rare Diseases or Conditions.[OL].http://fda.gov/Forlndustry[DevelopingProductsf orRareDiseawsConditions/Incentives/default.htm.
7EMEA.Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products[OL].全球法规网http://policy.mofcom.gov.cn/PDFView?id=fel787ee-5965-4de1-88de-7ed81830bece&libcode=flaw.[2000-1-22].
